Trials / Recruiting
RecruitingNCT04120701
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,980 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mFOLFOX6 | Patients receive adjuvant chemotherapy every 2 weeks during 6 months: FOLFOX6m (5-FU, leucovorin and oxaliplatin). |
Timeline
- Start date
- 2020-01-17
- Primary completion
- 2027-01-01
- Completion
- 2028-01-01
- First posted
- 2019-10-09
- Last updated
- 2021-10-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04120701. Inclusion in this directory is not an endorsement.